2B
20 Bio, Inc.
SEC filingBiotechnology · Somerville, MA
Amount raised$4.5Msold at filing
Total offering$6M$1.5M still open
Investors in the raise2count reported to the SEC
FiledFeb 13, 2026first sale Jan 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Julius KnowlesExecutive Officer, Director
Murthy ChavaliDirector
Executive officers, directors and promoters as listed on the Form D.